GRAL · NASDAQ · Healthcare · Diagnostics & Research

GRAIL, Inc.

Past month
Price unavailable
  • 52W range41.50–118.84
  • Market cap4.91B

Latest news

Loading...

About

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolut...

grail.com